Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jimenez, F.
Right arrow Articles by Dang, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jimenez, F.
Right arrow Articles by Dang, H.
Related Collections
Right arrow Sjogren's Syndrome
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2002; 41: 338-342
© 2002 British Society for Rheumatology


Original Papers

Activated caspase 3 and cleaved poly(ADP-ribose)polymerase in salivary epithelium suggest a pathogenetic mechanism for Sjögren's syndrome

F. Jimenez, S. Aiba-Masago, I. Al Hashimi1, N. Vela-Roch, G. Fernandes, C.-K. Yeh2, N. Talal3 and H. Dang

2 Departments of Medicine and Dental Diagnostic Sciences, University of Texas Health Science Center at San Antonio, San Antonio, Texas,
1 Baylor College of Dentistry, Dallas, Texas and
3 Columbia University College of Physicians & Surgeons, New York, NY, USA

Objective. Apoptosis is an organized energy-dependent process of cellular self-destruction carried out by proteolytic enzymes such as the caspases. These enzymes may play a role in epithelial cell apoptosis in Sjögren's syndrome (SS). A classical caspase substrate is poly(ADP-ribose)polymerase (PARP), a DNA repair enzyme. To elucidate the molecular mechanisms responsible for salivary gland dysfunction in SS, we studied the expression of caspase and PARP in SS salivary gland biopsies.

Methods. The presence of activated caspases (caspases 3 and 9) and cleaved PARP (85 kDa) in SS biopsies was demonstrated by immunohistochemistry using specific polyclonal antibodies.

Results. Initial studies performed with an antibody reagent that recognizes both active and inactive forms of caspase 3 identified this enzyme in SS salivary ductal and acinar cells. Activated caspase 3 and cleaved PARP were strongly expressed in ductal and acinar cells in SS salivary glands (13/15). Ductal and acinar cells from normal salivary glands (n=5) stained with less intensity compared with SS tissue. Staining for activated caspase 9 was negative in all samples. Likewise, infiltrating lymphocytes were negative for caspase 3, caspase 9 and cleaved PARP.

Conclusion. This study shows that caspase 3 is important in the salivary dysfunction of SS, while caspase 9 appears not to be involved.

KEY WORDS: Sjögren's syndrome, Apoptosis, Salivary gland, Caspase, CD95, Epithelial cells.

Correspondence to: H. Dang, Department of Community Dentistry, Mail Code 7917, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
W.-S. CHEN, K.-C. LIN, C.-H. CHEN, H.-T. LIAO, H.-P. WANG, W.-Y. LI, H.-T. LEE, C.-Y. TSAI, and C.-T. CHOU
Autoantibody and Biopsy Grading Are Associated with Expression of ICAM-1, MMP-3, and TRAIL in Salivary Gland Mononuclear Cells of Chinese Patients with Sjogren's Syndrome
J Rheumatol, May 1, 2009; 36(5): 989 - 996.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Ramos-Casals and J. Font
Primary Sjogren's syndrome: current and emergent aetiopathogenic concepts
Rheumatology, November 1, 2005; 44(11): 1354 - 1367.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. Bredberg, G. Henriksson, A. Larsson, R. Manthorpe, and A. Sallmyr
Sjogren's syndrome and the danger model
Rheumatology, August 1, 2005; 44(8): 965 - 970.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.